VanEck Biotech ETF (BBH) News Today → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free BBH Stock Alerts $167.99 -0.55 (-0.33%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 5:36 AM | americanbankingnews.comVanEck Biotech ETF (NASDAQ:BBH) Short Interest Down 16.0% in AprilMay 6, 2024 | marketbeat.comWhy Invest in Biotech Stocks (BBH)One fascinating sector to invest in is the biotech sector which includes companies involved in the research and development of therapeutics and vaccinesMarch 29, 2024 | benzinga.comFuture-Proof Your Portfolio: Learn From ETF Expert Jan Van Eck In NYCMarch 22, 2024 | seekingalpha.comGNOM: Genomics Still Waiting For Its 'ChatGPT' MomentJanuary 30, 2024 | msn.comVanEck CEO Says Cryptos Deserve A Place In Everyone's PortfolioDecember 19, 2023 | msn.comVanEck Vectors Biotech ETF declares annual distribution of $0.7127December 9, 2023 | seekingalpha.comBBH: A Solid Way To Play A Comeback In BiotechOctober 24, 2023 | investing.comBBH ETF Stock Price HistorySeptember 14, 2023 | marketbeat.comShort Interest in VanEck Biotech ETF (NASDAQ:BBH) Increases By 82.4%VanEck Biotech ETF (NASDAQ:BBH - Get Free Report) was the target of a significant increase in short interest in August. As of August 31st, there was short interest totalling 6,200 shares, an increase of 82.4% from the August 15th total of 3,400 shares. Based on an average trading volume of 6,400 shares, the days-to-cover ratio is currently 1.0 days.September 13, 2023 | msn.comBBH: Our Favorite Biotech ETF Can Keep OutperformingSeptember 4, 2023 | marketbeat.comQuintet Private Bank Europe S.A. Takes Position in VanEck Biotech ETF (NASDAQ:BBH)Quintet Private Bank Europe S.A. bought a new stake in shares of VanEck Biotech ETF (NASDAQ:BBH - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 4,004 shares of the compaAugust 30, 2023 | marketbeat.comLPL Financial LLC Has $7.81 Million Stock Position in VanEck Biotech ETF (NASDAQ:BBH)LPL Financial LLC lessened its stake in VanEck Biotech ETF (NASDAQ:BBH - Free Report) by 2.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 48,159 shares of the company's stock after selling 1,284 shares duAugust 20, 2023 | marketbeat.comTower Research Capital LLC TRC Boosts Stock Position in VanEck Biotech ETF (NASDAQ:BBH)Tower Research Capital LLC TRC grew its stake in VanEck Biotech ETF (NASDAQ:BBH - Free Report) by 38.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,051 shares of the company's stock after purchaAugust 7, 2023 | morningstar.comVanEck ETFsJune 2, 2023 | marketbeat.comMiller Investment Management LP Grows Position in VanEck Biotech ETF (NASDAQ:BBH)Miller Investment Management LP raised its stake in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) by 117.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 6,623 shares of the company's stock after acquiriMay 28, 2023 | marketbeat.comCommerce Bank Takes Position in VanEck Biotech ETF (NASDAQ:BBH)Commerce Bank acquired a new position in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 1,300 shares of the company's stock, valued at approximately $May 27, 2023 | msn.comBBH: A Solid Choice For Biotech ExposureMay 23, 2023 | marketbeat.comChevy Chase Trust Holdings LLC Purchases New Holdings in VanEck Biotech ETF (NASDAQ:BBH)Chevy Chase Trust Holdings LLC purchased a new stake in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 8,741 shares of the company's stocMay 13, 2023 | marketwatch.comVan Eck Biotech Etf $BBH Trading ReportMay 3, 2023 | marketwatch.comWhen the Price of Van Eck Biotech Etf $BBH Talks, People ListenApril 30, 2023 | marketbeat.comJanney Montgomery Scott LLC Sells 1,050 Shares of VanEck Biotech ETF (NASDAQ:BBH)Janney Montgomery Scott LLC trimmed its holdings in VanEck Biotech ETF (NASDAQ:BBH - Get Rating) by 13.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,520 shares of the company's stock after selling 1,050 shares during theApril 25, 2023 | seekingalpha.comBBH VanEck Biotech ETFApril 24, 2023 | marketwatch.comVan Eck Biotech Etf $BBH Pivots Trading Plans and Risk ControlsApril 20, 2023 | marketbeat.comKestra Advisory Services LLC Lowers Holdings in VanEck Biotech ETF (NASDAQ:BBH)Kestra Advisory Services LLC reduced its stake in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) by 8.3% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 18,353 shares of the company's stock after selling 1,668 shares during theApril 7, 2023 | marketbeat.comCyndeo Wealth Partners LLC Takes Position in VanEck Biotech ETF (NASDAQ:BBH)Cyndeo Wealth Partners LLC acquired a new stake in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 1,300 shares of the company's stoMarch 31, 2023 | marketbeat.comAspiriant LLC Has $1.21 Million Stock Position in VanEck Biotech ETF (NASDAQ:BBH)Aspiriant LLC boosted its stake in VanEck Biotech ETF (NASDAQ:BBH - Get Rating) by 63.9% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 7,583 shares of the company's stock after buying an additional 2,955 shares during the period. AspirianMarch 27, 2023 | marketwatch.comTrading Van Eck Biotech Etf $BBH With Integrated Risk ControlsMarch 24, 2023 | msn.comETFs in Focus on Sanofi and Regeneron's COPD Drug DataMarch 18, 2023 | morningstar.comVanEck Biotech ETF BBHMarch 17, 2023 | marketbeat.comAmerican Trust Takes $368,000 Position in VanEck Biotech ETF (NASDAQ:BBH)American Trust purchased a new stake in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 2,328 shares of the company's stock, valued at approximately $368,000. American TruMarch 10, 2023 | marketbeat.comVanEck Biotech ETF (NASDAQ:BBH) Short Interest Down 74.1% in FebruaryVanEck Biotech ETF (NASDAQ:BBH - Get Rating) was the recipient of a significant decrease in short interest in the month of February. As of February 28th, there was short interest totalling 2,200 shares, a decrease of 74.1% from the February 13th total of 8,500 shares. Based on an average daily volume of 11,000 shares, the days-to-cover ratio is currently 0.2 days.March 9, 2023 | marketbeat.comMML Investors Services LLC Buys New Stake in VanEck Biotech ETF (NASDAQ:BBH)MML Investors Services LLC bought a new stake in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 2,833 shares of the company's stock, valued at approximately $399,000. MMarch 2, 2023 | marketbeat.comWealthspire Advisors LLC Decreases Stake in VanEck Biotech ETF (NASDAQ:BBH)Wealthspire Advisors LLC lowered its position in VanEck Biotech ETF (NASDAQ:BBH - Get Rating) by 68.6% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 1,542 shares of the company's stock after selling 3,365 shares during the period. WealFebruary 28, 2023 | marketbeat.comTower Research Capital LLC TRC Sells 2,422 Shares of VanEck Biotech ETF (NASDAQ:BBH)Tower Research Capital LLC TRC trimmed its position in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) by 47.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,683 shares of the company's stock after sellingFebruary 1, 2023 | marketbeat.comFirst Republic Investment Management Inc. Acquires 10,515 Shares of VanEck Biotech ETF (NASDAQ:BBH)First Republic Investment Management Inc. lifted its holdings in VanEck Biotech ETF (NASDAQ:BBH - Get Rating) by 514.7% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 12,558 shares of the company'January 19, 2023 | marketbeat.comRaymond James Financial Services Advisors Inc. Grows Stake in VanEck Biotech ETF (NASDAQ:BBH)Raymond James Financial Services Advisors Inc. lifted its stake in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) by 11.4% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,654 shares of theJanuary 18, 2023 | marketbeat.comJanney Montgomery Scott LLC Lowers Stock Holdings in VanEck Biotech ETF (NASDAQ:BBH)Janney Montgomery Scott LLC lowered its holdings in shares of VanEck Biotech ETF (NASDAQ:BBH - Get Rating) by 7.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,570 shares of the company's stock aftDecember 23, 2022 | msn.comVanEck Vectors Biotech ETF declares annual distribution of $0.7488December 13, 2022 | marketbeat.comShort Interest in VanEck Biotech ETF (NASDAQ:BBH) Increases By 106.6%VanEck Biotech ETF (NASDAQ:BBH - Get Rating) saw a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 12,600 shares, an increase of 106.6% from the November 15th total of 6,100 shares. Based on an average daily volume of 12,800 shares, the days-to-cover ratio is presently 1.0 days.November 26, 2022 | nasdaq.comBiotech Finally Getting Its Groove BackNovember 11, 2022 | marketbeat.comShort Interest in VanEck Biotech ETF (NASDAQ:BBH) Increases By 182.1%VanEck Biotech ETF (NASDAQ:BBH - Get Rating) was the recipient of a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 31,600 shares, an increase of 182.1% from the October 15th total of 11,200 shares. Based on an average trading volume of 12,900 shares, the short-interest ratio is currently 2.4 days.October 21, 2022 | seekingalpha.comIBB iShares Biotechnology ETFOctober 15, 2022 | marketbeat.comVanEck Biotech ETF (NASDAQ:BBH) Short Interest Down 33.6% in SeptemberSeptember 30, 2022 | marketbeat.comVanEck Biotech ETF (NASDAQ:BBH) Short Interest Up 41.3% in SeptemberVanEck Biotech ETF (NASDAQ:BBH - Get Rating) saw a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 11,300 shares, an increase of 41.3% from the August 31st total of 8,000 shares. Based on an average daily volume of 15,100 shares, the short-interest ratio is presently 0.7 days.September 7, 2022 | nasdaq.comConsolidation Case for Biotech ETF BBHAugust 25, 2022 | uk.finance.yahoo.comVanEck Biotech ETF (BBH)August 17, 2022 | nasdaq.comBiotech Bounce-Back Could Be DurableAugust 11, 2022 | marketbeat.comShort Interest in VanEck Biotech ETF (NASDAQ:BBH) Decreases By 44.9%VanEck Biotech ETF (NASDAQ:BBH - Get Rating) saw a large drop in short interest in July. As of July 31st, there was short interest totalling 8,700 shares, a drop of 44.9% from the July 15th total of 15,800 shares. Based on an average trading volume of 24,900 shares, the short-interest ratio is presently 0.3 days.August 9, 2022 | nasdaq.comBiotech Rebound Could Finally Be AfootAugust 2, 2022 | nasdaq.comBank on BBH for Surprising Protection Get VanEck Biotech ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for BBH and its competitors with MarketBeat's FREE daily newsletter. Email Address The ONE AI Stock to own now. (It’s not Nvidia.) (Ad)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made … Click here to see the presentation now. BBH Media Mentions By Week BBH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BBH News Sentiment▼0.980.69▲Average Finance News Sentiment BBH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BBH Articles This Week▼10▲BBH Articles Average Week Get VanEck Biotech ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for BBH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PPH News Today PSCH News Today BIB News Today BTEC News Today IBBQ News Today IBB News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BBH) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaWhat’s Really Next for America…Porter & Company[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
